MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

“Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia

S. Sekimoto, G. Oyama, T. Jo, A. Nakajima, Y. Shimo, M. Nakajima, A. Umemura, M. Ito, H. Arai, N. Hattori (Bunkyo-ku, Japan)

Meeting: 2016 International Congress

Abstract Number: 40

Keywords: Deep brain stimulation (DBS), Dyskinesias, Dystonia: Treatment, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical therapy: Parkinson's disease

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To describe a patient underwent deep brain stimulation (DBS) with different target in left and right.

Background: DBS is a therapeutic option for movement disorders, including Parkinson’s disease (PD). Targets for DBS are commonly chosen symmetrically; e.g. bilateral subthalamic nucleus (STN) or bilateral globus pallidus interna (GPi). In this study we report DBS of the different target in right and left significantly improved severe unilateral dystonia in patient with familial PD.

Methods: A 49-year old man developed bradykinesia in the left upper and lower limb at the age of 39. Anti-Parkinson’s drugs were initially effective but he developed wearing-off and levodopa induced dyskinesia (LID) with dystonic component in the left upper limb at the age of 48. Because his dyskinesia and wearing off were difficult to control with medication, he decided to undergo DBS. As targets, right GPi was chosen to improve dystonia in his left upper extremity, and left STN was chosen because dystonia was absent in his left side and we expected to reduce medications. We evaluated the Unified Parkinson’s disease Rating Scale (UPDRS) Part III and Part IV score before and after the surgery.

Results: After the surgery, his symptoms was markedly improved (pre-operative: UPDRS Part III 21, Part IV 7, post-operative: UPDRS Part III 9, Part IV 4). Before the surgery he was taking ropinirol CR 16mg, levodopa/benzerazide 300mg, entacapone 300mg, zonisamide 50mg, after the surgery his medications reduced to ropinirol CR 14mg and levodopa/benzerazide 300mg.

Conclusions: Our case suggested that DBS with different target in left and right may be an effective therapeutic option for patients with different symptom in left and right.

The 9th Congress of The Movement Disorder Society of Japan, Oct 15-17, 2015. 5th Asian and Oceanian Parkinson’s disease and Movement Disorders Congress, March 11-13, 2016.

To cite this abstract in AMA style:

S. Sekimoto, G. Oyama, T. Jo, A. Nakajima, Y. Shimo, M. Nakajima, A. Umemura, M. Ito, H. Arai, N. Hattori. “Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/two-odd-targets-strategy-in-deep-brain-stimulation-for-parkinsons-disease-with-unilateral-dystonia/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/two-odd-targets-strategy-in-deep-brain-stimulation-for-parkinsons-disease-with-unilateral-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley